维普中文期刊产品整合服务
41篇 您的检索式:作者名="Cudkowicz"
    题名 作者 年代 出处 被引量
1Genetic control of the natural killer cell activity I SIL and other strains of mice 显示文摘Kaminsky S G Nakamura I Cudkowicz G 1985J Immunol1985,135,:1
2The blood supply of malignant pulmonary neoplasms显示文摘Cudkowicz L Armstrong J B 1953Thorax1953,8,2:1
3Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis 显示文摘Cudkowicz M E Mckenna-Yasek D Sapp P E 1997Ann Neurol1997,41,2:1
4Safety and dose escalating study of oral sodium phenylbutyrate in subjects with ALS显示文摘Cudkowicz ME Andrews PL Choudry R 2007Neurology2007,68,1:1
5Phase 2 study of sodium phenylbutyrate in ALS显示文摘Cudkowicz ME Andres PL Macdonald SA 2009Amyotroph Lateral Scler2009,10,2:1
6显示文摘Bruijn LI Cudkowicz M 2006Expert Rev Neurother2006,6,3:1
7Biomarkers for amyotrophie lateral sclerosis显示文摘Bowser R Cudkowicz M Kaddurah DR 2006Expert Rev Mol Diagn2006,6,3:1
8Epidemiology of mutations in superox- ide dismutase in amyotrophic lateral sclerosis显示文摘Cudkowicz ME McKerma-Yasek D Sapp PE 1997Ann Neurol1997,41,:1
9Biomarkers for amyotrophic lateral sclerosis 显示文摘Bowser R Cudkowicz M Kaddurah DR 2006Expert Rev Mol Diagn2006,6,3:1
10Phase Ⅱ/Ⅲ randomized trial of TCH346 in patients with ALS显示文摘Miller R Bradley W Cudkowicz M 2007Neurology2007,69,8:1
11Biomarkers for amyotrophic lateral sclerosis显示文摘Bowser R Cudkowicz M Kaddurah-Daouk R 2006Expert Rev Mol Diagn2006,6,3:1
12Intrathecal administration of recombinant human superoxide dismutase 1 in amyotrophic lateral sclerosis: a preliminary safety and pharmacokinetic study显示文摘Cudkowicz M E Warren L Francis J W 1997Neurology1997,49,1:1
13Dynamic markers of altered gait rhythm in amyotrophyic lateral sclerosis 显示文摘Hausdorff JM Lertratanakul A Cudkowicz ME 2000J Appl Physial2000,88,16:1
14Trial of celecoxib in amyotrophic lateral sclerosis显示文摘Cudkowicz ME Shefner JM Schoenfeld DA 2006Ann Neurol2006,60,1:1
15A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis 显示文摘Cudkowicz ME Shefner JM Schoenfeld DA 2003Neurology2003,61,4:1
16Epidemiology of mutation in superoxide dismutase in amyotrophic lateral sclerosis显示文摘Cudkowicz ME 1997Ann Neurol1997,41,2:1
17A clinical trial of creatine in ALS 显示文摘SHEFNER JM CUDKOWICZ ME SCHOENFELD D et ol 2004Neurology2004,63,9:1
18Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis:a multi-stage,randomised,double-blind,placebo-controlled trial显示文摘Cudkowicz ME Titus S Kearney M 2014Lancet Neurol2014,13,11:1
19Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis显示文摘CUDKOWICZ ME SHEFNER JM SIMPSON E 2008Muscle Nerve2008,38,1:1
20Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis显示文摘Cudkowicz ME McKenna-Yasek D Sapp PE 1997Ann Neurol1997,41,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费